AJANTPHARM2024-07-012024-09-30 AJANTPHARM2024-07-012024-09-30 AJANTPHARM2024-07-012024-09-30in-bse-fin:OneOperatingExpenses01Member AJANTPHARM2024-07-012024-09-30in-bse-fin:FourOperatingExpenses01Member AJANTPHARM2024-09-30 AJANTPHARM2024-07-012024-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member AJANTPHARM2024-07-012024-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member AJANTPHARM2024-07-012024-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member AJANTPHARM2024-07-012024-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532331 AJANTPHARM NOTLISTED Ajanta Pharma Limited Equity 2024-04-01 2025-03-31 2024-10-28 2024-10-17 INR Crores Half yearly 14:00:00 15:40:00 2024-10-28 2024-10-28 true Cash Flow Indirect Not applicable Single segment Pharmaceutical 2024-07-01 2024-09-30 Unaudited Consolidated 11866400000.00 194800000.00 12061200000.00 2070900000.00 457900000.00 88000000.00 2609600000.00 60200000.00 343900000.00 3528300000.00 9158800000.00 2902400000.00 0.00 2902400000.00 761100000.00 -23500000.00 737600000.00 0.00 2164800000.00 0.00 0.00 0.00 0.00 2164800000.00 57100000.00 2221900000.00 2164800000.00 0.00 2221900000.00 0.00 250700000.00 2 17.27 17.26 0.00 0.00 17.27 17.26 Notes : 1. The above consolidated financial results have been reviewed by Audit Committee and approved by the Board of Directors at their meeting held on 28 October 2024. The statutory auditors have expressed an unmodified opinion. The review report has been filed with the stock exchange and is available on company website. 2. The consolidated unaudited financial results of the Company, its wholly owned subsidiaries and step-down subsidiary (“the Group”) have been prepared as per Ind AS 110 on Consolidated Financial Statements. There is no minority interest. 3. Board of Directors have approved 1st interim dividend of Rs. 350 Crore for financial year 2024-25 to its shareholders @ Rs. 28 per share on the face value of Rs. 2 per share. 4. Other income / Other expense includes : Quarter ended Half year ended Year ended 30-Sep-24 30-Jun-24 30-Sep-23 30-Sep-24 30-Sep-23 31-Mar-24 Foreign exchange gain (in other income) 12.13 8.26 12.81 12.39 23.90 38.69 Foreign exchange loss (in other expense) 25.65 - - 17.65 1.40 - 5. During half year 25,325 (previous year 1,000) equity shares of Rs. 2 each, fully paid up, were allotted upon exercise of vested options pursuant to the Share Based Incentive Plan, 2019, resulting in an increase in the paid-up share capital by Rs. 50,650 (previous year Rs. 2,000) and securities premium by Rs. 3.84 crores (previous year Rs. 0.18 crores). 6. On 2 May 2024, Company has announced buy back of its 10,28,881 equity shares, being 0.82% of the total paid up equity share capital at Rs. 2,770 per equity share for an aggregate amount of Rs. 285.00 crores. The buy back opened on 05 June 2024, closed on 11 June 2024 and Company extinguished those shares on 27 June 2024. Single segment 2024-04-01 2024-09-30 Unaudited Consolidated 23315600000.00 459500000.00 23775100000.00 4455000000.00 910700000.00 -70400000.00 5447400000.00 67500000.00 683600000.00 6157700000.00 17651500000.00 6123600000.00 0.00 6123600000.00 1554900000.00 -53800000.00 1501100000.00 0.00 4622500000.00 0.00 0.00 0.00 0.00 4622500000.00 -16300000.00 4606200000.00 4622500000.00 0.00 4606200000.00 0.00 250700000.00 2 36.88 36.86 0.00 0.00 36.88 36.86 Other Expenses 3528300000.00 Other Expenses 6157700000.00 0.00 13604900000.00 3487600000.00 0.00 0.00 908500000.00 0.00 0.00 0.00 248300000.00 0.00 0.00 91700000.00 340000000.00 1463900000.00 152300000.00 19957200000.00 8456600000.00 6769800000.00 10164300000.00 638900000.00 10400000.00 202000000.00 155700000.00 17941100000.00 0.00 1461600000.00 27859300000.00 88500000.00 0.00 47905000000.00 250700000.00 36518800000.00 36769500000.00 36769500000.00 24200000.00 0.00 3711600000.00 3735800000.00 883900000.00 1125600000.00 0.00 21700000.00 5767000000.00 0.00 4208800000.00 0.00 4208800000.00 607700000.00 0.00 552000000.00 0.00 5368500000.00 0.00 0.00 11135500000.00 47905000000.00 Notes : 1. The above consolidated financial results have been reviewed by Audit Committee and approved by the Board of Directors at their meeting held on 28 October 2024. The statutory auditors have expressed an unmodified opinion. The review report has been filed with the stock exchange and is available on company website. 2. The consolidated unaudited financial results of the Company, its wholly owned subsidiaries and step-down subsidiary (“the Group”) have been prepared as per Ind AS 110 on Consolidated Financial Statements. There is no minority interest. 3. Board of Directors have approved 1st interim dividend of Rs. 350 Crore for financial year 2024-25 to its shareholders @ Rs. 28 per share on the face value of Rs. 2 per share. 4. Other income / Other expense includes : Quarter ended Half year ended Year ended 30-Sep-24 30-Jun-24 30-Sep-23 30-Sep-24 30-Sep-23 31-Mar-24 Foreign exchange gain (in other income) 12.13 8.26 12.81 12.39 23.90 38.69 Foreign exchange loss (in other expense) 25.65 - - 17.65 1.40 - 5. During half year 25,325 (previous year 1,000) equity shares of Rs. 2 each, fully paid up, were allotted upon exercise of vested options pursuant to the Share Based Incentive Plan, 2019, resulting in an increase in the paid-up share capital by Rs. 50,650 (previous year Rs. 2,000) and securities premium by Rs. 3.84 crores (previous year Rs. 0.18 crores). 6. On 2 May 2024, Company has announced buy back of its 10,28,881 equity shares, being 0.82% of the total paid up equity share capital at Rs. 2,770 per equity share for an aggregate amount of Rs. 285.00 crores. The buy back opened on 05 June 2024, closed on 11 June 2024 and Company extinguished those shares on 27 June 2024. 67500000.00 -170000000.00 2373800000.00 0.00 -127500000.00 3800000.00 1900000.00 34500000.00 0.00 -421000000.00 0.00 1600000.00 0.00 683600000.00 5300000.00 -5800000.00 276800000.00 508600000.00 -1500000.00 -51100000.00 0.00 310700000.00 25700000.00 222800000.00 0.00 0.00 0.00 -1700000.00 0.00 3116600000.00 9240200000.00 0.00 0.00 0.00 1475600000.00 0.00 7764600000.00 0.00 0.00 16282300000.00 19697900000.00 0.00 0.00 0.00 62500000.00 5500000.00 1497400000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 210700000.00 0.00 2400000.00 0.00 -4756900000.00 0.00 0.00 0.00 0.00 3536000000.00 0.00 0.00 0.00 9300000.00 0.00 0.00 79700000.00 0.00 53500000.00 0.00 0.00 -3659900000.00 -652200000.00 -3800000.00 -656000000.00 1294900000.00 638900000.00 Amount of items that will not be reclassified to profit and loss -24000000.00 Amount of items that will not be reclassified to profit and loss -61400000.00 -24000000.00 -61400000.00 -8400000.00 -21500000.00 Amount of items that will be reclassified to profit and loss 72700000.00 Amount of items that will be reclassified to profit and loss 23600000.00 72700000.00 23600000.00 0.00 0.00